Synthetic Biologics, Inc.
BETA-LACTAMASE COMPOSITIONS FOR TREATMENT OF GRAFT VERSUS HOST DISEASE

Last updated:

Abstract:

The present invention relates to, in part, methods and compositions for reducing the incidence and/or severity of complications associated with IV beta-lactam antibiotic use in allo-HCT recipients, such as aGVHD and VRE colonization and/or VRE bloodstream infection, using beta-lactamase agents.

Status:
Application
Type:

Utility

Filling date:

5 May 2020

Issue date:

14 Jul 2022